Spark Newswire Spark Newswire
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
News by Category
  • After-Hours Center
  • Analyst Color
  • Analyst Ratings
  • Asia
  • Asset Sales
  • Binary Options
  • Biotech
  • Bonds
  • Broad U.S. Equity ETFs
  • Buybacks
  • Cannabis
  • Commodities
  • Contracts
  • Crowdsourcing
  • Cryptocurrency
  • Currency ETFs
  • Dividends
  • Downgrades
  • Earnings
  • Earnings Beats
  • Earnings Misses
  • Econ #s
  • Economics
  • Education
  • Emerging Market ETFs
  • Emerging Markets
  • Entertainment
  • Entrepreneurship
  • ESG
  • ETFs
  • Eurozone
  • Events
  • Exclusives
  • FDA
  • Federal Reserve
  • Financial Advisors
  • Financing
  • Fintech
  • Forex
  • Futures
  • Gaming
  • General
  • Global
  • Government
  • Guidance
  • Health Care
  • Hedge Funds
  • Hot
  • Initiation
  • Insider Trades
  • Insurance
  • Interview
  • Intraday Update
  • IPOs
  • Large Cap
  • Latin America
  • Legal
  • Long Ideas
  • M&A
  • Macro Economic Events
  • Management
  • Market-Moving Exclusives
  • Markets
  • Media
  • Mid Cap
  • Movers
  • Movers & Shakers
  • Mutual Funds
  • New ETFs
  • News
  • Offerings
  • Opinion
  • Options
  • Penny Stocks
  • Personal Finance
  • Politics
  • Pre-Market Outlook
  • Press Releases
  • Previews
  • Price Target
  • Psychedelics
  • Psychology
  • Real Estate
  • Regulations
  • REIT
  • Reiteration
  • Restaurants
  • Retail Sales
  • Reviews
  • Rumors
  • SEC
  • Sector ETFs
  • Short Ideas
  • Short Sellers
  • Signals
  • Small Business
  • Small Cap
  • Small Cap Analysis
  • Small-Cap
  • Social Media
  • SPACE
  • Specialty ETFs
  • Sports
  • Sports Betting
  • Startups
  • Stock Split
  • Success Stories
  • Tech
  • Technicals
  • Termination
  • Top Stories
  • Topics
  • Trading Ideas
  • Travel
  • Treasuries
  • Uncategorized
  • Upgrades
Spark Newswire Spark Newswire
Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
Spark Newswire Spark Newswire
Filter By Ticker
Search By Date To
Today | Yesterday | This week
Browsing Category

Guidance

Group By Ticker
Sort By
Newest | Oldest
Read More
1 minute read
  • Guidance
  • News

Altria FY23 Adj. EPS Outlook $4.98 – $5.13 Vs. $5.00 Est

By Benzinga Newsdesk
Today, 8:03 AM
We expect our 2023 full-year adjusted diluted EPS to be in a range of $4.98 to $5.13, representing a growth rate of 3% to 6% from an adjusted diluted EPS base of $4.84 in 2022. While the 2023 full-year adjusted diluted

MO

Read More
1 minute read
  • Biotech
  • Earnings
  • General
  • Guidance
  • Health Care
  • Large Cap
  • Movers
  • News
  • Trading Ideas

Novartis Reports Mixed Bag Q4 Earnings, Forecasts Higher Sales, Profits Ahead Of Sandoz Spin-Off

By Vandana Singh
Today, 6:47 AM
Novartis AG (NYSE:NVS) has reported Q4 core EPS of $1.52 compared to $1.40 a year ago, beating the consensus of $1.44.…

NVS

Read More
1 minute read
  • Earnings
  • Earnings Beats
  • General
  • Guidance
  • Health Care
  • Large Cap
  • News

Edwards Lifesciences Q4 Earnings Beats Street Estimates, Expects Easing Of Macro Headwinds Later In 2023

By Vandana Singh
Today, 6:34 AM
Edwards Lifesciences Corp (NYSE:EW) reported Q4 adjusted EPS of $0.64, up 25% Y/Y and higher than the consensus of $0.61.…

EW

Read More
2 minute read
  • Guidance
  • News

BXP Sees Q1 2023 EPS Of $0.52-$0.54 And FFO Of $1.66-$1.68, FY23 EPS Of $2.36-$2.46 And FFFO Of $7.08-$7.18

By Happy Mohamed
Today, 1:15 AM
EPS and FFO per Share Guidance: BXP's guidance for the first quarter 2023 and full year 2023 for EPS (diluted) and FFO per share (diluted) is set forth and reconciled below. Except as

BXP

Read More
1 minute read
  • Guidance
  • News

Advanced Micro Devices Says In PC Market, We Are Planning For PC Total Addressable Market To Be Down ~10% For 2023, Says As We Enter 2023 Expect Overall Demand Environment To Remain Mixed With H2 Stronger Than H1

By Michael Horton
Yesterday, 6:12 PM
-Reuters

AMD

Read More
1 minute read
  • After-Hours Center
  • Earnings
  • Guidance
  • Movers
  • News

Why Western Digital Shares Are Sliding After Hours

By Adam Eckert
Yesterday, 5:59 PM
Western Digital Corp (NASDAQ: WDC) shares fell in Tuesday's after-hours session after the company reported mixed fiscal second-quarter results and 

WDC

Read More
3 minute read
  • Earnings
  • Guidance
  • News
  • Tech
  • Top Stories

AMD Stock Rallies Following Q4 Beat: Chipmaker Weathers PC Market Weakness With Strong Server Chip Sales

By Shanthi Rexaline
Yesterday, 5:55 PM
Advanced Micro Devices, Inc.

AMD

Read More
2 minute read
  • After-Hours Center
  • Earnings
  • Gaming
  • General
  • Guidance
  • Movers
  • News
  • Top Stories
  • Trading Ideas

Electronic Arts Q3 Earnings Highlights: Shares Fall On Cautious Guidance, But This Game Is Hitting Record Engagement

By Chris Katje
Yesterday, 5:34 PM
Video game company Electronic Arts Inc (NASDAQ: EA) reported third-quarter financial results after the market close Tuesday. Here are the key highlights for investors. 

EA

Read More
1 minute read
  • Guidance
  • News

Edwards Lifesciences Sees FY23 Sales $5.6B-$6B Vs $5.78B Est; Q1 2023 EPS $0.58-$0.64 Vs $0.59 Est; Q1 2023 Revenue $1.37B-$1.45B Vs $1.37B Est

By Happy Mohamed
Yesterday, 5:21 PM
Outlook Overall, the company is reaffirming the sales guidance it provided at the December investor conference for all product groups.  Full year 2023 sales are expected to grow 9 to 12

EW

Read More
1 minute read
  • Guidance
  • News

Mercury Systems Sees Q3 23 EPS $0.32-$0.42 Vs $0.61 Est.; Q3 23 Revenue $245M-$260M Vs $266.61M Est

By Happy Mohamed
Yesterday, 5:13 PM
For the third quarter of fiscal 2023, revenues are forecasted to be in the range of $245.0 million to $260.0 million. GAAP net (loss) income for the third quarter is expected to be

MRCY

Posts navigation

1 2 … 450 Next
Free Newsletter subscribe

Stock Market Ideas & Analysis

Stay up-to-date with the same information professionals use.
Spark Newswire Spark Newswire
  • Newswire
  • Registration
  • Log In
  • Settings
  • Privacy Policy
  • Terms of Service
© 2021 Spark Newswire
All Rights Reserved.

All news is property of their respective owners. Terms of Service